Revenue segments as reported by the company.

Instruments & Accessories

Systems

Services

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Intuitive Surgical

Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Intuitive Surgical reports robust Q4 performance and eyes future growth

Intuitive Surgical's Q4 2022 showcased strong performance and growth in procedures and system placements.
While facing challenges like macroeconomic uncertainty and supply chain costs, the company is poised for continued innovation.
Opportunities lie in expanding markets, advancing technology, and improving surgical outcomes through collaboration.
Investments in industrial scale, automation, and platform advancements signal a strategic focus on future growth.

Intuitive Surgical (ISRG) reports robust Q1 performance and growth outlook

Intuitive Surgical (ISRG) delivered strong Q1 results with revenue up 14% and exceeding procedure growth expectations.
While facing challenges in manufacturing and supply chain, the company is focusing on R&D progress and inventory replenishment.
The outlook for 2023 looks promising with increased procedure growth forecasts and a focus on improving patient outcomes and market expansion.
Overall, Intuitive Surgical (ISRG) is well-positioned to capitalize on opportunities for growth and innovation in the robotic surgery market.

Intuitive Surgical excels in Q2 performance, eyes AI opportunities

Intuitive Surgical's Q2 2023 performance showcased strong revenue growth, procedure increases, and a focus on healthcare improvement.
The company's strengths include innovative ecosystem investments, commitment to patient outcomes, and advanced surgical technologies.
Challenges include market disruptions from new drugs, expense management, and adapting to changing healthcare landscapes.
Opportunities in AI, market expansion, and new procedures position Intuitive Surgical for continued growth and innovation.

Intuitive Surgical excels in Q3, eyes global expansion and margin growth

Intuitive Surgical's Q3 performance reflects strong growth and strategic focus on innovation and market expansion. Despite challenges in specific procedure categories and pricing dynamics, the company is well-positioned to capitalize on opportunities for growth and margin improvement.

Intuitive Surgical posts strong 2023 results, da Vinci 5 launch ahead

Intuitive Surgical's 2023 performance reflects strong revenue growth, operational excellence, and a strategic focus on innovation with the upcoming da Vinci 5 launch.
While facing challenges in operating margin pressure and supply chain issues, the company is well-positioned to capitalize on opportunities in soft tissue surgery, big data integration, and leased placements.
Investors should monitor how Intuitive Surgical navigates the launch of da Vinci 5, manages operational challenges, and leverages growth opportunities to sustain its market leadership.
Overall, Intuitive Surgical's Q4 earnings call highlights a resilient business model, customer-centric approach, and a commitment to advancing surgical technology for better patient outcomes.

Intuitive Surgical posts robust Q1 results amidst global market challenges

Intuitive Surgical delivered strong Q1 results with notable procedure and revenue growth, despite challenges in certain markets.
The company's focus on newer platforms, operational efficiency, and strategic outlook for 2024 positions it for continued success.
Addressing challenges and seizing opportunities in global markets and product innovation will be key for sustained growth and competitiveness.

Intuitive Surgical excels in Q2, eyes global expansion and innovation

Intuitive Surgical's Q2 performance reflects strength in procedure growth and system platform advancements.
The company's commitment to innovation and value creation positions them well for future success.
Challenges include sustaining margins and navigating market dynamics, while opportunities lie in expansion and innovation.
Overall, Intuitive Surgical's focus on growth, technology, and patient care sets a positive trajectory for the future.

Intuitive Surgical excels in Q3 with strong growth and innovation

Intuitive Surgical's Q3 2024 performance reflects a company in a strong position with notable achievements in procedures, financials, and technological advancements. While facing challenges in margin progression and international expansion, the company is well-positioned to leverage opportunities in innovation and customer insights.

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Honeywell

Nauticus Robotics Inc

In the ever-evolving world of technology, robotics has emerged as a sector with immense potential. The quest for automation and efficiency has led to the development of some of the best robotics stocks to buy.

If You Can Only Buy One Robotics Stock, It Better Be One of These 3 Names

Intuit

Over the near term, the indices are likely to move higher, but an autumn correction looms. Here are a pair of stock recommendations, one long and one short.

Stocks This Week: Buy Intuit And Sell Short Intuitive Surgical

Exact Sciences

Exact Sciences develops innovative diagnostics tests that help intercept cancer early. Intuitive Surgical's famous robotic surgical system has important benefits for patients.

2 Revolutionary Stocks to Buy and Hold for 10 Years

Timing is everything. Intuitive Surgical, Inc. NASDAQ: ISRG delighted investors by beating revenue and earnings expectations when it reported second-quarter earnings after the market closed on July 20.

ISRG Stock Sinks After Strong Earnings: Is the Growth Priced In?

Intuitive Surgical (NASDAQ:ISRG) shares slipped on weaker demand for bariatric surgeries during the second quarter despite outperforming the Street's expectations on profit and sales. The company, which develops and manufactures robotic surgery solutions aimed at improving clinical outcomes, told investors on Thursday that it had seen waning demand for robot-assisted bariatric surgeries amid the rising popularity of obesity drugs, sending its shares lower.

Intuitive Surgical stock slips on slowing growth of bariatric surgeries during 2Q

Intuitive Surgical, Inc. (NASDAQ:ISRG ) Q2 2023 Earnings Conference Call July 20, 2023 4:30 PM ET Company Participants Brian King - Head of IR Gary Guthart - CEO Jamie Samath - CFO Conference Call Participants Larry Biegelsen - Wells Fargo Travis Steed - Bank of America Robbie Marcus - JPMorgan Rick Wise - Stifel Richard Newitter - Truist Securities Ryan Zimmerman - BTIG Drew Ranieri - Morgan Stanley Operator Ladies and gentlemen, thank you for standing by and welcome to the Intuitive Q2 2023 Earnings Release. At this time all participants are in a listen-only mode.

Intuitive Surgical, Inc. (ISRG) Q2 2023 Earnings Call Transcript

While the top- and bottom-line numbers for Intuitive Surgical, Inc. (ISRG) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Intuitive Surgical, Inc. (ISRG) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Markets were mostly lower, although the Dow gained ground. CSX stock fell as the railroad industry faced some challenges.

Why 2 Key Stocks Dropped After Hours Thursday

Intuitive Surgical Inc beat Wall Street estimates for quarterly sales and profit on Thursday, boosted by a rise in total procedures volume of its surgical robot da Vinci.

Intuitive Surgical beats profit, revenue estimates

Intuitive Surgical Inc.'s ISRG, -0.58% stock tumbled 6% in extended trading Thursday after the health care giant reported quarterly earnings that came up short of analysts' estimates. Intuitive Surgical reported fiscal second-quarter net income of $426 million, or $1.18 a share, compared with net income of $307.8 million, or 85 cents a share, in the year-ago quarter.

Intuitive Surgical's stock falls on earnings miss

Intuitive Surgical topped second-quarter expectations on Thursday, but shares of the robotic surgery giant tumbled in late action.

Robotic Surgery Behemoth Intuitive Surgical Beats Expectations, But Crumbles

Intuitive Surgical's (ISRG) second-quarter results are likely to reflect solid performance in the Instruments & Accessories segment. However, rising costs may have hurt margins.

Intuitive Surgical (ISRG) to Post Q2 Earnings: What's in Store?

American Express

Carvana

Schlumberger

Before U.S. markets opened on Wednesday, Carvana Co. (NYSE: CVNA) reported quarterly results earlier than originally planned.

Earnings Previews: American Express, CSX, Intuitive Surgical, Schlumberger (Plus a Carvana Surprise)

C3.ai

CrowdStrike

Medtronic

Micron Technology

NVIDIA

Palo Alto Networks

Symbotic Inc

Advancement in AI has helped give tech stocks their best-performing first half of the year since 1983. Big-tech executives continue to remain bullish over the ongoing demand for AI. Wall Street analysts are now touting tech stocks in different market segments.

Tech Bulls Continue Their Rally For These AI Stock Picks

Abbott Labs

Among the broader healthcare space, Abbott Laboratories (ABT) and Intuitive Surgical (ISRG) are two medical stocks that will highlight this week's earnings lineup.

2 Medical Stocks to Buy as Earnings Approach

UiPath

Rockwell Automation

While some investors may be soaking up the July sun, the smart money is closely watching robotics stocks. This is a realm that artificial intelligence has more than supercharged.

3 Robotics Stocks That AI Is Loving in July

Broadcom

Zscaler

The Nasdaq index rebalancing will change the weights of key stocks within the fund. Big tech stocks will have a lower concentration within the index.

3 Nasdaq Stocks to Watch After Index Rebalancing

ABB Ltd.

Amazon

Global X Robotics & Artificial Intelligence ETF

Lockheed Martin

Teradyne

Robots play an increasingly large role in our lives, whether we realize it or not. Today, robots are used in everything from manufacturing our household appliances to navigating the cars we drive, performing surgery on us, and delivering packages to our homes.

The 7 Best Robotics Stocks to Buy in July

We expect the company's revenues to come in at $1.7 billion, aligning with the consensus estimate.

Here's What To Expect From Intuitive Surgical's Q2

Analog Devices

Automatic Data Processing

Booking Hlds

Gilead Sciences

Mondelez

Starbucks

While the market rally this year has been an investor's dream after the nightmare of last year, the reality is that a handful of red-hot technology stocks running higher on the back of the Artificial Intelligence explosion has created almost all of the gains in the S&P 500 and the Nasdaq.

With The Massive NASDAQ Rebalance Coming Soon 7 ‘Strong Buy' Stocks Could Explode Higher

Johnson & Johnson

Pfizer

Teladoc

Healthcare stocks stumbled in the first half as investors favored higher-growth industries. Investors piled into technology and consumer discretionary stocks.

Should You Buy the First Half's Worst-Performing Sector?

Wall Street analysts see Intuitive Surgical's shares falling soon. Its high valuation is a risk that might help analyst estimates pan out.

Wall Street Thinks Intuitive Surgical Stock Will Fall, But Investors Should Be Skeptical

Medtronic is going through an "aggressive transformation" to accelerate growth. In the robotic surgery market, Intuitive Surgical has a hugely dominant position.

Better Buy: Medtronic vs. Intuitive Surgical

Intuitive Surgical is a leading player in the Medical Instruments & Supplies industry, specializing in advanced robotic systems that revolutionize minimally invasive surgeries. The company has a strong track record and is expected to maintain double-digit sales growth, capitalizing on the increasing use of surgical robots in various procedures. Despite the high stock valuation, recent developments and an upgraded financial outlook make Intuitive Surgical stock an attractive investment, particularly if bought during a market correction.

Intuitive Surgical: Aggressive Wealth Compounding In Healthcare

Apple

Exxon Mobil

Intuitive Surgical's robotic systems are improving patient outcomes. ExxonMobil is quickly becoming a leader in low-carbon energy solutions.

News for Intuitive Surgical Stock (ISRG)